Abbott India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve the Unaudited Financial Results ....
RESULTS
◆ Monitor Closely
LOW RISK
📅 Filed on BSE: 04 Aug 2026, 04:57 PM IST · BSE ID: 5b5c5158-3e49-40a8-b4d5-afc33706f3ac
View Original BSE Filing (PDF)
💡
In Simple Terms
Abbott India's board will meet on August 12, 2026, to review and approve the company's first quarter financial results.
🤖 AI Summary
- Abbott India's Board will meet on August 12, 2026, to approve Unaudited Financial Results for the quarter ended June 30, 2026.
- The board meeting is scheduled in compliance with Regulation 29(1)(a) of SEBI (LODR) Regulations, 2015.
- Company's trading window is closed from July 1, 2026, to August 14, 2026, for insider trading compliance.
- This closure allows for the formal consideration and approval of the first quarter FY27 financial outcomes.
- The results will cover the financial performance for the period ending June 30, 2026.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required from shareholders based on this announcement.
👤
Who Is Affected
All shareholders will be affected by the upcoming financial results for the quarter ended June 30, 2026, once they are approved and disclosed.
🔍
Management Signal
The scheduled board meeting indicates management is adhering to regulatory timelines for quarterly financial reporting.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Board Meeting Outcome on August 12, 2026 — for Q1 FY27 results approval.
Release of Unaudited Financial Results for Q1 FY27 — detailing performance figures.
Trading window reopening on August 15, 2026 — post results announcement.
LOW RISK
The filing is a routine board meeting intimation without new financial data or operational changes.
💡 Investor Takeaway
Abbott India's Board of Directors is scheduled to convene on August 12, 2026, to consider and approve the Unaudited Financial Results for the quarter ended June 30, 2026. The trading window is closed from July 1, 2026, to August 14, 2026.
📅 Company Track Record
Abbott India's FY26 profit rose 9.73% to Rs. 1,552.02 Crores, with revenue up 8.11% for the year ended March 31, 2026. A dividend of Rs. 656/- per share was recommended in May 2026 for FY26.
Based on publicly available historical data. For context only.
❓ Frequently Asked Questions
When is Abbott India's Board of Directors meeting?
Abbott India's Board of Directors meeting is scheduled for Wednesday, August 12, 2026.
What is the purpose of Abbott India's upcoming board meeting?
The purpose of Abbott India's upcoming board meeting is to consider and approve the Unaudited Financial Results for the quarter ended June 30, 2026.
What is the trading window closure period for Abbott India?
The trading window for Abbott India is closed from Wednesday, July 1, 2026, to Friday, August 14, 2026 (both days inclusive).
Which SEBI Regulation governs this Abbott India announcement?
This Abbott India announcement is made under Regulation 29 (1) (a) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Questions based on this BSE filing only. For information purposes.